Delayed
Nasdaq
10:23:11 2024-05-21 am EDT
5-day change
1st Jan Change
2.811
USD
-1.01%
-1.71%
-5.98%
This article is reserved for members
Not a member ?
Free registration
Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 30
CI
Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Feb. 28
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 28
CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 28
CI
Transcript : Nautilus Biotechnology, Inc., Q3 2023 Earnings Call, Oct 31, 2023
23-10-31
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
23-10-31
CI
Transcript : Nautilus Biotechnology, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 10:50 AM
23-09-13
Transcript : Nautilus Biotechnology, Inc., Q2 2023 Earnings Call, Aug 02, 2023
23-08-02
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-02
CI
Transcript : Nautilus Biotechnology, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 04:40 PM
23-06-12
Transcript : Nautilus Biotechnology, Inc., Q1 2023 Earnings Call, May 02, 2023
23-05-02
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-02
CI
Transcript : Nautilus Biotechnology, Inc., Q4 2022 Earnings Call, Feb 23, 2023
23-02-23
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
23-02-23
CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-02-23
CI
Nautilus Biotechnology Expands to San Diego
23-01-26
CI
Nautilus Biotechnology, Translational Genomics Research Institute Team Up to Advance Study in Childhood Cancer
23-01-19
MT
Nautilus Biotechnology, Inc. Partners with the Translational Genomics Research Institute to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma
23-01-19
CI
Transcript : Nautilus Biotechnology, Inc., Q3 2022 Earnings Call, Nov 01, 2022
22-11-01
Nautilus Biotechnology, Inc. Appoints Karen Akinsanya to Nominating Committee
22-11-01
CI
Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-01
CI
Global markets live: Ford, Biogen, Exxon, Generac Holdings, Nautilus...
22-09-27
Sterling's fall and recession fears sent Wall Street in bear territory
22-09-27
MarketScreener's World Press Review : September 27, 2022
22-09-27
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Companyâs products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Companyâs Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.
More about the company
Last Close Price
2.84
USD
Average target price
4.25
USD
Spread / Average Target
+49.65%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1